S Stípek Selected Research

Atherosclerosis

1/2005	[Advanced glycation and oxidation products in patients with atherosclerosis].
3/2004	[Ferritin, oxidative stress and coronary atherosclerosis].
1/2004	Hyperlipoproteinemia impairs endothelium-dependent vasodilation.
1/2002	Antibodies against oxidized low density lipoproteins in pregnant women.
1/2001	Oxidative stress, metabolism of ethanol and alcohol-related diseases.
1/2000	[Fatty acid composition and parameters of VLDL and LDL in persons with dyslipidemia].
1/2000	[Effect of fat distribution on lipoprotein composition and parameters of lipoperoxidation].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Stípek Research Topics

Disease

7	Atherosclerosis 01/2005 - 01/2000
2	Pre-Eclampsia (Preeclampsia) 01/2004 - 01/2002
2	Dyslipidemias (Dyslipidemia) 01/2000 - 01/2000
2	Insulin Resistance 01/2000 - 01/2000
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2004
1	Vascular Diseases (Vascular Disease) 03/2004
1	Hyperlipoproteinemias 01/2004
1	Hypoglycemia (Reactive Hypoglycemia) 01/2003
1	Hypertriglyceridemia 04/2002
1	Congenital Abnormalities (Deformity) 01/2002
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2002
1	Liver Diseases (Liver Disease) 01/2001
1	Corneal Injuries 01/2001
1	Diabetes Complications 01/2001
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2001
1	Atherosclerotic Plaque (Atheroma) 01/2000
1	Overweight 01/2000
1	Hyperlipidemias (Hyperlipidemia) 01/2000
1	Hyperuricemia 01/2000
1	Obesity 01/2000

Drug/Important Bio-Agent (IBA)

6	oxidized low density lipoproteinIBA 01/2004 - 01/2000
4	Lipoproteins (Lipoprotein)IBA 01/2004 - 01/2000
2	Advanced Oxidation Protein Products (AOPP)IBA 01/2005 - 01/2004
2	LipidsIBA 01/2004 - 01/2000
2	Immunoglobulin G (IgG)IBA 01/2004 - 01/2002
2	Glucose (Dextrose)FDA LinkGeneric 01/2003 - 01/2000
2	AntibodiesIBA 01/2002 - 01/2001
2	low density lipoprotein inhibitorIBA 01/2000 - 01/2000
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2000 - 01/2000
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2005
1	Biological ProductsIBA 01/2005
1	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 01/2005
1	Ferritins (Ferritin)IBA 03/2004
1	IronIBA 03/2004
1	Immunoglobulin M (IgM)IBA 01/2004
1	HDL CholesterolIBA 01/2004
1	NitratesIBA 01/2004
1	NitritesIBA 01/2004
1	Triglycerides (Triacylglycerol)IBA 01/2004
1	Malondialdehyde (Propanedial)IBA 01/2004
1	Insulin (Novolin)FDA Link 01/2003
1	Fibric Acids (Fibrates)IBA 04/2002
1	Proteins (Proteins, Gene)FDA Link 01/2002
1	Biomarkers (Surrogate Marker)IBA 01/2002
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2001
1	CytokinesIBA 01/2001
1	Antiphospholipid AntibodiesIBA 01/2001
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2001
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2001
1	Oxidoreductases (Dehydrogenase)IBA 01/2001
1	Xanthine OxidaseIBA 01/2001
1	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 01/2001
1	Hemostatics (Antihemorrhagics)IBA 01/2000

Therapy/Procedure

1	Therapeutics 01/2005